266 related articles for article (PubMed ID: 33512384)
1. Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases.
Ghosh MC; Zhang DL; Ollivierre WH; Noguchi A; Springer DA; Linehan WM; Rouault TA
Blood; 2021 May; 137(18):2509-2519. PubMed ID: 33512384
[TBL] [Abstract][Full Text] [Related]
2. The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice.
Hickey MM; Richardson T; Wang T; Mosqueira M; Arguiri E; Yu H; Yu QC; Solomides CC; Morrisey EE; Khurana TS; Christofidou-Solomidou M; Simon MC
J Clin Invest; 2010 Mar; 120(3):827-39. PubMed ID: 20197624
[TBL] [Abstract][Full Text] [Related]
3. Translational repression of HIF2α expression in mice with Chuvash polycythemia reverses polycythemia.
Ghosh MC; Zhang DL; Ollivierre H; Eckhaus MA; Rouault TA
J Clin Invest; 2018 Apr; 128(4):1317-1325. PubMed ID: 29480820
[TBL] [Abstract][Full Text] [Related]
4. Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2α.
Ghosh MC; Zhang DL; Jeong SY; Kovtunovych G; Ollivierre-Wilson H; Noguchi A; Tu T; Senecal T; Robinson G; Crooks DR; Tong WH; Ramaswamy K; Singh A; Graham BB; Tuder RM; Yu ZX; Eckhaus M; Lee J; Springer DA; Rouault TA
Cell Metab; 2013 Feb; 17(2):271-81. PubMed ID: 23395173
[TBL] [Abstract][Full Text] [Related]
5. von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.
Hickey MM; Lam JC; Bezman NA; Rathmell WK; Simon MC
J Clin Invest; 2007 Dec; 117(12):3879-89. PubMed ID: 17992257
[TBL] [Abstract][Full Text] [Related]
6. The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption.
Anderson SA; Nizzi CP; Chang YI; Deck KM; Schmidt PJ; Galy B; Damnernsawad A; Broman AT; Kendziorski C; Hentze MW; Fleming MD; Zhang J; Eisenstein RS
Cell Metab; 2013 Feb; 17(2):282-90. PubMed ID: 23395174
[TBL] [Abstract][Full Text] [Related]
7. IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation.
Wilkinson N; Pantopoulos K
Blood; 2013 Aug; 122(9):1658-68. PubMed ID: 23777768
[TBL] [Abstract][Full Text] [Related]
8. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
Gong K; Zhang N; Zhang K; Na Y
Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
[TBL] [Abstract][Full Text] [Related]
9. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway.
Yang M; Zhu M; Song K; Wuren T; Yan J; Ge RL; Ji L; Cui S
Life Sci; 2021 Feb; 266():118873. PubMed ID: 33309718
[TBL] [Abstract][Full Text] [Related]
10. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.
Tan Q; Kerestes H; Percy MJ; Pietrofesa R; Chen L; Khurana TS; Christofidou-Solomidou M; Lappin TR; Lee FS
J Biol Chem; 2013 Jun; 288(24):17134-44. PubMed ID: 23640890
[TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation.
Formenti F; Beer PA; Croft QP; Dorrington KL; Gale DP; Lappin TR; Lucas GS; Maher ER; Maxwell PH; McMullin MF; O'Connor DF; Percy MJ; Pugh CW; Ratcliffe PJ; Smith TG; Talbot NP; Robbins PA
FASEB J; 2011 Jun; 25(6):2001-11. PubMed ID: 21389259
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo.
Rankin EB; Biju MP; Liu Q; Unger TL; Rha J; Johnson RS; Simon MC; Keith B; Haase VH
J Clin Invest; 2007 Apr; 117(4):1068-77. PubMed ID: 17404621
[TBL] [Abstract][Full Text] [Related]
13. JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension.
Sala MA; Chen C; Zhang Q; Do-Umehara HC; Wu W; Misharin AV; Waypa GB; Fang D; Budinger GRS; Liu S; Chandel NS; Schumacker PT; Sznajder JI; Liu J
J Biol Chem; 2018 Jan; 293(1):271-284. PubMed ID: 29118187
[TBL] [Abstract][Full Text] [Related]
14. Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing.
Zhang X; Zhang W; Ma SF; Miasniakova G; Sergueeva A; Ammosova T; Xu M; Nekhai S; Nourai M; Wade MS; Prchal JT; Garcia JGN; Machado RF; Gordeuk VR
Blood Cells Mol Dis; 2014 Jan; 52(1):35-45. PubMed ID: 23993337
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia).
Sable CA; Aliyu ZY; Dham N; Nouraie M; Sachdev V; Sidenko S; Miasnikova GY; Polyakova LA; Sergueeva AI; Okhotin DJ; Bushuev V; Remaley AT; Niu X; Castro OL; Gladwin MT; Kato GJ; Prchal JT; Gordeuk VR
Haematologica; 2012 Feb; 97(2):193-200. PubMed ID: 21993671
[TBL] [Abstract][Full Text] [Related]
16. The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high-energy phosphate metabolism.
Slingo M; Cole M; Carr C; Curtis MK; Dodd M; Giles L; Heather LC; Tyler D; Clarke K; Robbins PA
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H759-67. PubMed ID: 27422990
[TBL] [Abstract][Full Text] [Related]
17. A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2
Pang Y; Gupta G; Yang C; Wang H; Huynh TT; Abdullaev Z; Pack SD; Percy MJ; Lappin TRJ; Zhuang Z; Pacak K
BMC Cancer; 2018 Mar; 18(1):286. PubMed ID: 29534684
[TBL] [Abstract][Full Text] [Related]
18. The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension.
Sarangi S; Lanikova L; Kapralova K; Acharya S; Swierczek S; Lipton JM; Wolfe L; Prchal JT
Pediatr Blood Cancer; 2014 Nov; 61(11):2104-6. PubMed ID: 24729484
[TBL] [Abstract][Full Text] [Related]
19. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.
Frey H; Moreth K; Hsieh LT; Zeng-Brouwers J; Rathkolb B; Fuchs H; Gailus-Durner V; Iozzo RV; de Angelis MH; Schaefer L
Glycoconj J; 2017 Jun; 34(3):393-404. PubMed ID: 27600268
[TBL] [Abstract][Full Text] [Related]
20. Altered cytokine profiles in patients with Chuvash polycythemia.
Niu X; Miasnikova GY; Sergueeva AI; Polyakova LA; Okhotin DJ; Tuktanov NV; Nouraie M; Ammosova T; Nekhai S; Gordeuk VR
Am J Hematol; 2009 Feb; 84(2):74-8. PubMed ID: 19062180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
